UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:January 31,
CNS Pharmaceuticals (NASDAQ:CNSP)
Historical Stock Chart
From Sep 2024 to Oct 2024 Click Here for more CNS Pharmaceuticals Charts.
CNS Pharmaceuticals (NASDAQ:CNSP)
Historical Stock Chart
From Oct 2023 to Oct 2024 Click Here for more CNS Pharmaceuticals Charts.

Cns Pharmaceuticals, Inc. News

Form PRE 14A - Other preliminary proxy statements
Wednesday 16 October 2024 (4 days ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 19 September 2024 (1 month ago) • Edgar (US Regulatory)
Form 8-K - Current report
Thursday 12 September 2024 (1 month ago) • Edgar (US Regulatory)
IBN Announces Latest Episode of The BioMedWire Podcast featuring John Climaco, CEO of CNS Pharmaceuticals Inc.
Tuesday 3 September 2024 (2 months ago) • GlobeNewswire Inc.
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 15 August 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 7 August 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 7 August 2024 (2 months ago) • Edgar (US Regulatory)
Form 3 - Initial statement of beneficial ownership of securities
Wednesday 7 August 2024 (2 months ago) • Edgar (US Regulatory)
Form SC 13D - General Statement of Acquisition of Beneficial Ownership
Saturday 3 August 2024 (3 months ago) • Edgar (US Regulatory)
Form RW - Registration Withdrawal Request
Thursday 1 August 2024 (3 months ago) • Edgar (US Regulatory)
Form 424B3 - Prospectus [Rule 424(b)(3)]
Wednesday 31 July 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 31 July 2024 (3 months ago) • Edgar (US Regulatory)

More Cns Pharmaceuticals, Inc. News Articles